Continuous interferon-γ or tumor necrosis factor-α exposure of enterocytes attenuates cell death responses

Cytokine

Volumn 27, Issue 4-5, 2004, Pages 113-119

  Seidelin, Jakob B ^a   Jäättelä, Marja ^b   Nielsen, Ole Haagen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Apoptosis; CD95; Cytokines; Intestinal; Proliferation

Indexed keywords

FAS ANTIGEN; FAS LIGAND; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; CELL PROLIFERATION; HT29 CELLS; HUMANS; INTERFERON TYPE II; INTESTINES; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3242669888     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.04.001     Document Type: Article

References (37)

1. Vainer B., Nielsen O.H. Changed colonic profile of p-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol. 121:2000;242-247
2. Beck P.L., Podolsky D.K. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis. 5:1999;44-60
3. Bleiberg H., Mainguet P., Galand P., Chretien J., Dupont-Mairesse N. Cell renewal in the human rectum. In vitro autoradiographic study on active ulcerative colitis. Gastroenterology. 58:1970;851-855
4. Booth C., Potten C.S. Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest. 105:2000;1493-1499
5. Brynskov J., Nielsen O.H., Ahnfelt-Ronne I., Bendtzen K. Cytokines in inflammatory bowel disease. Scand J Gastroenterol. 27:1992;897-906
6. Decker T., Lohmann-Matthes M.L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods. 115:1988;61-69
7. Dignass A.U. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis. 7:2001;68-77
8. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 48:2001;526-535
9. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:2001;342-348
10. Farrell R.J., Banerjee S., Peppercorn M.A. Recent advances in inflammatory bowel disease. Crit Rev Clin Lab Sci. 38:2001;33-108
11. Farrell R.J., Peppercorn M.A. Ulcerative colitis. Lancet. 359:2002;331-340
12. Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science. 218:1982;474-475
13. Green D.R. Apoptotic pathways: the roads to ruin. Cell. 94:1998;695-698
14. Green L.M., Reade J.L., Ware C.F. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods. 70:1984;257-268
15. Heinen C.D., Noffsinger A.E., Belli J., Straughen J., Fischer J., Groden J., et al. Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer. 19:1997;170-175
16. Heyman M., Desjeux J.F. Cytokine-induced alteration of the epithelial barrier to food antigens in disease. Ann N Y Acad Sci. 915:2000;304-311
17. Hiribarren A., Heyman M., L'Helgouac'h A., Desjeux J.F. Effect of cytokines on the epithelial function of the human colon carcinoma cell line HT29 cl 19A. Gut. 34:1993;616-620
18. Iimura M., Nakamura T., Shinozaki S., Iizuka B., Inoue Y., Suzuki S., et al. Bax is downregulated in inflamed colonic mucosa of ulcerative colitis. Gut. 47:2000;228-235
19. Iwamoto M., Koji T., Makiyama K., Kobayashi N., Nakane P.K. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 180:1996;152-159
20. Katz J. The course of inflammatory bowel disease. Med Clin North Am. 78:1994;1275-1280
21. Kim K.M., Lee K., Hong Y.S., Park H.Y. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells. Exp Mol Med. 32:2000;246-254
22. Mahraoui L., Heyman M., Plique O., Droy-Lefaix M.T., Desjeux J.F. Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumor necrosis factor-alpha. Gut. 40:1997;339-343
23. Masuda H., Iwai S., Tanaka T., Hayakawa S. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J Clin Lab Immunol. 46:1995;111-123
24. Naishiro Y., Yamada T., Takaoka A.S., Hayashi R., Hasegawa F., Imai K., et al. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res. 61:2001;2751-2758
25. Naujokat C., Sezer O., Possinger K. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells. Biochem Biophys Res Commun. 264:1999;813-819
26. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 139:1991;271-279
27. O'Connell J., Bennett M.W., Nally K., O'Sullivan G.C., Collins J.K., Shanahan F. Interferon-gamma sensitizes colonic epithelial cell lines to physiological and therapeutic inducers of colonocyte apoptosis. J Cell Physiol. 185:2000;331-338
28. Ossina N.K., Cannas A., Powers V.C., Fitzpatrick P.A., Knight J.D., Gilbert J.R., et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem. 272:1997;16351-16357
29. Rich T., Allen R.L., Wyllie A.H. Defying death after DNA damage. Nature. 407:2000;777-783
30. Ruemmele F.M., Russo P., Beaulieu J., Dionne S., Levy E., Lentze M.J., et al. Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol. 181:1999;45-54
31. Serafini E.P., Kirk A.P., Chambers T.J. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut. 22:1981;648-652
32. Strater J., Wellisch I., Riedl S., Walczak H., Koretz K., Tandara A., et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 113:1997;160-167
33. Tamir S., Tannenbaum S.R. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta. 1288:1996;F31-F36
34. Terpend K., Boisgerault F., Blaton M.A., Desjeux J.F., Heyman M. Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma. Gut. 42:1998;538-545
35. Tsai S.C., Gaffney E.V. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon. J Natl Cancer Inst. 79:1987;77-81
36. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683
37. Xu X., Fu X.Y., Plate J., Chong A.S. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 58:1998;2832-2837